Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Jul;50(7):586–590. doi: 10.1136/jcp.50.7.586

Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.

C Charpin 1, S Garcia 1, C Bouvier 1, F Martini 1, M Lavaut 1, C Allasia 1, P Bonnier 1, L Andrac 1
PMCID: PMC500062  PMID: 9306940

Abstract

AIM: To determine the prognostic significance and clinical relevance of cathepsin D detected by immunocytochemical assays (ICAs) in breast carcinomas. METHODS: 151 patients presenting with palpable or impalpable breast carcinomas and who had not received any kind of adjuvant chemotherapy or endocrine therapy who were operated from January 1986 to May 1987 were studied. ICAs of tumour specimens were performed in optimal technical conditions (frozen sections, automated immunoperoxidase technique (Ventana), and computer assisted analysis of digitised coloured microscopic images (SAMBA)) to determine cathepsin D immunocytochemical expression. Results of quantitative ICAs were correlated with overall and disease free survival over 8.4 years of follow up in axillary lymph node positive and negative patients. RESULTS: Cathepsin D immunocytochemical expression in tumours of 15% or more was significantly associated with poor overall survival in the whole group and in node positive patients (Kaplan Meier, log rank test p = 0.003 and p = 0.007); however, it was not correlated with survival in node negative patients. Cathepsin D immunocytochemical expression (> 15%) correlated with short disease free (p = 0.015) and short recurrence free survival (p = 0.021) in the group as a whole but not when node positive and negative patients were evaluated separately. CONCLUSIONS: In optimal conditions (automated and quantitative ICAs on frozen sections) cathepsin D immunohistochemical expression is a significant prognostic indicator in terms of overall, disease free, and recurrence free survival; however, there is no correlation when node negative patients are considered separately.

Full text

PDF
586

Images in this article

587Image
on p.587
587Image
on p.587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltonen M., Lipponen P., Kosma V. M., Aaltomaa S., Syrjänen K. Prognostic value of cathepsin-D expression in female breast cancer. Anticancer Res. 1995 May-Jun;15(3):1033–1037. [PubMed] [Google Scholar]
  2. Altman D. G., Lausen B., Sauerbrei W., Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994 Jun 1;86(11):829–835. doi: 10.1093/jnci/86.11.829. [DOI] [PubMed] [Google Scholar]
  3. BLOOM H. J. G. Prognosis in carcinoma of the breast. Br J Cancer. 1950 Sep;4(3):259–288. doi: 10.1038/bjc.1950.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Briozzo P., Morisset M., Capony F., Rougeot C., Rochefort H. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res. 1988 Jul 1;48(13):3688–3692. [PubMed] [Google Scholar]
  5. Brugal G., Garbay C., Giroud F., Adelh D. A double scanning microphotometer for image analysis: hardware, software and biomedical applications. J Histochem Cytochem. 1979 Jan;27(1):144–152. doi: 10.1177/27.1.374569. [DOI] [PubMed] [Google Scholar]
  6. Charpin C., Devictor B., Bonnier P., Andrac L., Lavaut M. N., Allasia C., Piana L. Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors. J Pathol. 1993 Aug;170(4):463–470. doi: 10.1002/path.1711700410. [DOI] [PubMed] [Google Scholar]
  7. Charpin C., Pellissier J. F. Marqueurs moléculaires dans les cancers du sein: aspect pratique et évaluation morphologique. Bull Acad Natl Med. 1994 Mar;178(3):475–493. [PubMed] [Google Scholar]
  8. Eng Tan P., Benz C. C., Dollbaum C., Moore D. H., 2nd, Edgerton S. M., Zava D. T., Thor A. D. Prognostic value of Cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assay. Ann Oncol. 1994 Apr;5(4):329–336. doi: 10.1093/oxfordjournals.annonc.a058836. [DOI] [PubMed] [Google Scholar]
  9. Freiss G., Vignon F., Rochefort H. Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells. Cancer Res. 1988 Jul 1;48(13):3709–3715. [PubMed] [Google Scholar]
  10. Gion M., Mione R., Dittadi R., Romanelli M., Pappagallo L., Capitanio G., Friede U., Barbazza R., Visonà A., Dante S. Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer. Eur J Cancer. 1995;31A(5):671–677. doi: 10.1016/0959-8049(94)00532-a. [DOI] [PubMed] [Google Scholar]
  11. Göhring U. J., Scharl A., Thelen U., Ahr A., Crombach G., Titius B. R. Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods. J Clin Pathol. 1996 Jan;49(1):57–64. doi: 10.1136/jcp.49.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Henry J. A., McCarthy A. L., Angus B., Westley B. R., May F. E., Nicholson S., Cairns J., Harris A. L., Horne C. H. Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer. 1990 Jan 15;65(2):265–271. doi: 10.1002/1097-0142(19900115)65:2<265::aid-cncr2820650214>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  13. Isola J., Weitz S., Visakorpi T., Holli K., Shea R., Khabbaz N., Kallioniemi O. P. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncol. 1993 Jan;11(1):36–43. doi: 10.1200/JCO.1993.11.1.36. [DOI] [PubMed] [Google Scholar]
  14. Isola J., Weitz S., Visakorpi T., Holli K., Shea R., Khabbaz N., Kallioniemi O. P. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncol. 1993 Jan;11(1):36–43. doi: 10.1200/JCO.1993.11.1.36. [DOI] [PubMed] [Google Scholar]
  15. Kandalaft P. L., Chang K. L., Ahn C. W., Traweek S. T., Mehta P., Battifora H. Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer. Cancer. 1993 May 1;71(9):2756–2763. doi: 10.1002/1097-0142(19930501)71:9<2756::aid-cncr2820710912>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  16. Maudelonde T., Brouillet J. P., Roger P., Giraudier V., Pages A., Rochefort H. Immunostaining of cathepsin D in breast cancer: quantification by computerised image analysis and correlation with cytosolic assay. Eur J Cancer. 1992;28A(10):1686–1691. doi: 10.1016/0959-8049(92)90069-e. [DOI] [PubMed] [Google Scholar]
  17. McGuire W. L., Clark G. M. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med. 1992 Jun 25;326(26):1756–1761. doi: 10.1056/NEJM199206253262607. [DOI] [PubMed] [Google Scholar]
  18. Namer M., Ramaioli A., Fontana X., Etienne M. C., Héry M., Jourlait A., Milano G., Frenay M., François E., Lapalus F. Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients. Breast Cancer Res Treat. 1991 Oct;19(2):85–93. doi: 10.1007/BF01980938. [DOI] [PubMed] [Google Scholar]
  19. Rochefort H., Capony F., Garcia M., Cavaillès V., Freiss G., Chambon M., Morisset M., Vignon F. Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem. 1987 Sep;35(1):17–29. doi: 10.1002/jcb.240350103. [DOI] [PubMed] [Google Scholar]
  20. Roger P., Montcourrier P., Maudelonde T., Brouillet J. P., Pages A., Laffargue F., Rochefort H. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Hum Pathol. 1994 Sep;25(9):863–871. doi: 10.1016/0046-8177(94)90004-3. [DOI] [PubMed] [Google Scholar]
  21. Romain S., Muracciole X., Varette I., Bressac C., Brandone H., Martin P. M. La cathepsine-D: un facteur pronostique indépendant dans le cancer du sein. Bull Cancer. 1990;77(5):439–447. [PubMed] [Google Scholar]
  22. Spyratos F., Maudelonde T., Brouillet J. P., Brunet M., Defrenne A., Andrieu C., Hacene K., Desplaces A., Rouëssé J., Rochefort H. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet. 1989 Nov 11;2(8672):1115–1118. doi: 10.1016/s0140-6736(89)91487-6. [DOI] [PubMed] [Google Scholar]
  23. Tandon A. K., Clark G. M., Chamness G. C., Chirgwin J. M., McGuire W. L. Cathepsin D and prognosis in breast cancer. N Engl J Med. 1990 Feb 1;322(5):297–302. doi: 10.1056/NEJM199002013220504. [DOI] [PubMed] [Google Scholar]
  24. Thorpe S. M., Rochefort H., Garcia M., Freiss G., Christensen I. J., Khalaf S., Paolucci F., Pau B., Rasmussen B. B., Rose C. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res. 1989 Nov 1;49(21):6008–6014. [PubMed] [Google Scholar]
  25. Têtu B., Brisson J., Côté C., Brisson S., Potvin D., Roberge N. Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study. Int J Cancer. 1993 Sep 30;55(3):429–435. doi: 10.1002/ijc.2910550318. [DOI] [PubMed] [Google Scholar]
  26. Veneroni S., Daidone M. G., Di Fronzo G., Cappelletti V., Amadori D., Riccobon A., Paradiso A., Correale M., Silvestrini R. Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables. Breast Cancer Res Treat. 1993;26(1):7–13. doi: 10.1007/BF00682695. [DOI] [PubMed] [Google Scholar]
  27. Westley B., Rochefort H. Estradiol induced proteins in the MCF7 human breast cancer cell line. Biochem Biophys Res Commun. 1979 Sep 27;90(2):410–416. doi: 10.1016/0006-291x(79)91250-6. [DOI] [PubMed] [Google Scholar]
  28. Winstanley J. H., Leinster S. J., Cooke T. G., Westley B. R., Platt-Higgins A. M., Rudland P. S. Prognostic significance of cathepsin-D in patients with breast cancer. Br J Cancer. 1993 Apr;67(4):767–772. doi: 10.1038/bjc.1993.139. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES